Phenotypic variation in familial chilblain lupus (FCL) and Aicardi-Goutières syndrome (AGS) associated with TREX1 mutation in 4 family members

Autor: Ryder Clive, Davis Penny, Crow Yanick, Taibjee Saleem, Glanville James, Southwood Taunton

Publikováno v: Pediatric Rheumatology Online Journal, Vol 9, Iss Suppl 1, p P283 (2011)

Externí odkaz: https://doaj.org/article/ef64c329207d4ac7a6486d7e1f4e6789

Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study

Autor: Kearsley-Fleet, Lianne, Heaf, Eleanor, Davies, Rebecca, Baildam, Eileen, Beresford, Michael W, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L ^*

Publikováno v: In The Lancet Rheumatology April 2020 2(4):e217-e226

Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis.

Autor: Kearsley-Fleet, Lianne, Baildam, Eileen, Beresford, Michael W, Douglas, Sharon, Foster, Helen E, Southwood, Taunton R, Hyrich, Kimme L, Ciurtin, Coziana

Publikováno v: Rheumatology; May2023, Vol. 62 Issue 5, p1926-1935, 10p

Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis

Autor: Kearsley-Fleet, Lianne, Vicente González, Laura, Steinke, Douglas, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Beresford, Michael W, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L

Publikováno v: Rheumatology (Oxford, England)

Objectives This analysis aims to calculate MTX monotherapy persistence and describe the occurrence of and factors associated with the occurrence of adverse drug reactions (ADRs) with MTX. Methods Patients with JIA starting MTX monotherapy from two UK

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d323d5f2d45ba10d179d2919cfa3eeb4
http://europepmc.org/articles/PMC6649753

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra

Autor: Kearsley-Fleet, Lianne, Beresford, Michael W, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L, Dis, Biologics Children Rheumatic

Publikováno v: Rheumatology (Oxford, England)
RHEUMATOLOGY
Kearsley-Fleet, L, Beresford, M W, Davies, R, De Cock, D, Baildam, E, Foster, H E, Southwood, T R, Thomson, W, Hyrich, K L & Biologics for Children with Rheumatic Diseases Study (BCRD) 2019, ' Short-Term Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis Treated with either Tocilizumab or Anakinra ', Rheumatology (Oxford), vol. 58, no. 1, pp. 94-102 . https://doi.org/10.1093/rheumatology/key262

Objectives To investigate real-world short-term outcomes among patients with systemic JIA starting tocilizumab or anakinra. Methods This analysis included all systemic JIA patients within the UK Biologics for Children with Rheumatic Diseases study st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff89dce7fd1afb5b2ae4989dbed4d264
https://doi.org/10.1093/rheumatology/key262